International Urology and Nephrology

, Volume 44, Issue 2, pp 377–384 | Cite as

Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials

  • Huantao Zong
  • Chenchen Yang
  • Xiaoxia Peng
  • Yong ZhangEmail author
Urology – Original Paper



The purpose of this analysis was to evaluate the efficacy and safety of desmopressin for the treatment of nocturia.


Databases including MEDLINE, EMBASE, ISI web of knowledge, the Cochrane Controlled Trial Register of Controlled Trials and Chinese Biological Medical Database were searched to identify randomized controlled trials (RCTs) that referred to the efficacy and safety of desmopressin for the treatment of nocturia. A systematic review and meta-analysis were conducted.


Five studies involving 619 participants were included for the meta-analysis, and 8 RCTs of cross-over design were also identified for the systematic review. The analysis revealed that desmopressin might significantly decrease the frequency of nocturnal voids, nocturnal urine volume and nocturnal diuresis, potentially resulting in an extended duration of the first sleep period and improved sleep quality. The adverse effects of desmopressin were similar to those observed in the placebo group.


Administered desmopressin was an effective and well-tolerated treatment for nocturia.


Desmopressin Nocturia Nocturnal polyuria Efficacy Safety 



We thank American Journal Experts for assisting in the preparation of this manuscript.

Conflict of interest

The authors had no conflicts of interest to declare in relation to this article.


  1. 1.
    van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weiss J (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183PubMedCrossRefGoogle Scholar
  2. 2.
    Markland AD, Vaughan CP, Johnson TM II, Goode PS, Redden DT, Burgio KL (2011) Prevalence of nocturia in United States men: results from the national health and nutrition examination survey. J Urol 185:998–1002PubMedCrossRefGoogle Scholar
  3. 3.
    Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK (2009) Nocturia and disturbed sleep in the elderly. Sleep Med 10:540–548PubMedCrossRefGoogle Scholar
  4. 4.
    Burgio KL, Johnson TM II, Goode PS, Markland AD, Richter HE, Roth DL, Sawyer P, Allman RM (2010) Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc 58:861–866PubMedCrossRefGoogle Scholar
  5. 5.
    Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I (2009) A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol 55:783–791PubMedCrossRefGoogle Scholar
  6. 6.
    Eckford SD, Carter PG, Jackson SR, Penney MD, Abrams P (1995) An open, inpatient, incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol 76:459–463PubMedCrossRefGoogle Scholar
  7. 7.
    Bannister R (1992) Treatment of antonomic failure. Curr Opin Neurol Neurosurg 5:487–491PubMedGoogle Scholar
  8. 8.
    Bosma R, Wynia K, Havlíková E, De Keyser J, Middel B (2005) Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand 112:1–5PubMedCrossRefGoogle Scholar
  9. 9.
    Mansson W, Swindin T, Gullberg B (1980) Evaluation of a synthetic wasopressin analogue for treatment of nocturia in benign prostatic hyperplasia. Scand J Urol Nephrol 14:139–141PubMedCrossRefGoogle Scholar
  10. 10.
    Wang CJ, Lin YN, Huang SW (2011) Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol 185:219–223PubMedCrossRefGoogle Scholar
  11. 11.
    Weatherall M (2004) The risk of hyponatremia in older adults using desmopressin for nocturia: A systematic review and meta-analysis. Neurourol Urodyn 23:302–305PubMedCrossRefGoogle Scholar
  12. 12.
    Fu FG, Lavery HJ, Wu DL (2011) Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin. Neurourol Urodyn 30:312–316PubMedCrossRefGoogle Scholar
  13. 13.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP (2007) Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol 52:221–229PubMedCrossRefGoogle Scholar
  14. 14.
    Mattiasson A, Abrams P, van Kerrebroeck P, Walter S, Weiss J (2002) Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 89:855–862PubMedCrossRefGoogle Scholar
  15. 15.
    Lose G, Lalos O, Freeman RM, van Kerrebroeck P (2003) Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind placebo-controlled study in women. Am J Obstet Gynecol 189:1106–1113PubMedCrossRefGoogle Scholar
  16. 16.
    Eckford SD, Swami KS, Jackson SR, Abrams PH (1994) Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 74:733–735PubMedCrossRefGoogle Scholar
  17. 17.
    Fredrikson S (1996) Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand 94:31–34PubMedCrossRefGoogle Scholar
  18. 18.
    Valiquette G, Herbert J, Maede-D’Alisera P (1996) Desmopressin in the management of nocturia in patients with multiple sclerosis: a double-blind, crossover trial. Arch Neurol 53:1270–1275PubMedCrossRefGoogle Scholar
  19. 19.
    Hoverd PA, Fowler CJ (1998) Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 65:778–780PubMedCrossRefGoogle Scholar
  20. 20.
    Asplund R, Sundberg B, Bengtsson P (1999) Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int 83:591–595PubMedCrossRefGoogle Scholar
  21. 21.
    Cannon A, Carter PG, Mcconnell AA, Abrams P (1999) Desmopressin in the treatment of noturnal polyuria in the male. BJU Int 84:20–24PubMedCrossRefGoogle Scholar
  22. 22.
    Hvistendahl GM, Riis A, Norgaard JP, Djurhuus JC (2005) The pharmacokinetics of 400 ug of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. BJU Int 95:804–809PubMedCrossRefGoogle Scholar
  23. 23.
    Johnson TM, Burridge A, Issa MM, Miller M, Tang T, Ouslander JG (2007) The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in oldermen: a pilot study. J Am Geriatr Soc 55:562–569PubMedCrossRefGoogle Scholar
  24. 24.
    Rembratt A, Norgaard JP, Andersson KE (2003) Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns. BJU Int 91:642–646PubMedCrossRefGoogle Scholar
  25. 25.
    Callréus T, Ekman E, Andersen M (2005) Hyponatremia in elderly patients treated with desmopressin for nocturia: a review of a case series. Eur J Clin Pharmacol 61:281–284PubMedCrossRefGoogle Scholar
  26. 26.
    Maserejian NN, Kupelian V, Link CL, McKinlay JB (2011) Modifiable lifestyle behaviors and incidence of lower urinary tract symptoms and urine leakage in a population-based study of men and women. J Urol (Suppl) 185:e18Google Scholar
  27. 27.
    Vilhardt H (1990) Basic pharmacology of desmopressin: a review. Drug Invest (Suppl) 2:2–8Google Scholar

Copyright information

© Springer Science+Business Media, B.V. 2011

Authors and Affiliations

  • Huantao Zong
    • 1
  • Chenchen Yang
    • 1
  • Xiaoxia Peng
    • 2
  • Yong Zhang
    • 1
    Email author
  1. 1.Department of Urology, Beijing Chao-Yang HospitalCapital Medical UniversityChao Yang District, BeijingChina
  2. 2.School of Public Health and Family MedicineCapital Medical UniversityBeijingChina

Personalised recommendations